Risks of Melanoma, Other Skin Cancers Are Higher in Patients Treated With Biologics for Psoriasis
Source: AJMC, February 2024
It is important to study the safety of targeted therapies in populations at increased risk of skin cancer, according to the researchers.
Patients treated with biologics for psoriasis had higher risks of melanoma and nonmelanoma skin cancer (NMSC) compared with the general population, according to a recent study.
These findings suggest a need for a better understanding of skin cancer risks associated with targeted therapies in patients with psoriasis.
